Despite Vaccines, the Need for Rapid COVID-19 Tests Remains
The need for rapid COVID-19 tests will certainly continue throughout 2021, despite the great progress made on vaccines. Shots will reach everyone who wants them, sooner or later, but perhaps not as quickly as we may like. Rapid tests could be made available right now, without a prescription, so we don’t have to wait months for the vaccine to arrive.
IN THE NEWS | The call for rapid, point-of-need testing gets louder
In Civil Beat this week, reporter Stewart Yerton explored how the calls for fast, frequent and cheap Covid-19 tests are growing stronger by the day. Experts agree that rapid tests can be the critical piece of the puzzle to solve the spread of Covid-19. By detecting infectiousness rather than just presence of the SARS-CoV-2 virus, we can effectively quarantine those who would readily spread the disease – regardless of if that person exhibits or experiences symptoms or not.
The Aloha Protocol for a safer reopening with ASSURE-19
As Oceanit moves ahead with in-vitro and in-vivo testing for the ASSURE-19 rapid point-of-need test kits, Hawaii is seeing high, sustained counts for new covid-19 cases each day. Check out the latest articles and coverage of ASSURE-19 from the Washington Post, Hawaii Public Radio, and Honolulu Star Advertiser.
ASSURE-19 Featured on Hawaii News Now, Honolulu Star Advertiser, and Pacific Business News
Oceanit is focusing on quickly bringing ASSURE-19 to market, organizing manufacturing so that we can provide schools, emergency responders, and airports with a simple saliva test to make high-risk situations safer. This phase of funding and work will help with regulatory compliance and approval, as well as support for accelerating a ‘go to market’ timeline and scale manufacturing.
Honolulu Star Advertiser: Hawaii coronavirus saliva test could help turn pandemic’s tide
CEO Dr. Patrick Sullivan spoke to The Star Advertiser’s Mindy Pennybacker about how the ASSURE-19 rapid “spit test” can help to protect lives and responsibly help to restore the economy and the unique ‘capture and detector molecule’ approach to COVID-19 respiratory disease detection. Click to read more.